Shopping Cart is Empty..

$ 0

Nov 2017 | 199 Views

Platelet Rich Plasma Market by Product (Pure PRP, Leukocyte Rich PRP, and Leukocyte Rich Fibrin), by Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), and by Application (Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI 172741	Pages: NA	Formats*:
Nov 2017 \| 199 Views	Charts: NA	Tables: NA	Author(s): NA

Platelet rich plasma (PRP) is derived from blood. It is produced when the human blood is spun down and platelet rich plasma is separated that have a concentration of platelets above the normal values. Platelets help in blood clotting as well as enhance the healing of tendons, muscles, and ligaments. PRP is used in different surgeries such as augmentation of shoulder rotator cuff and tendon repair.

Platelets are extremely rich in healing factors and connective tissue growth.

The major factors that enhance the market growth are growth in geriatric population, increase in incidence of sports and orthopedic injuries, rise in number of cosmetic surgical procedures, technological advancements, and increase in awareness regarding PRP therapies. However, difficulty in quality control of test results, thereby restrain the market growth.

The market is segmented based on product, origin, application, and geography. By product, this market is categorized into pure PRP, leukocyte rich PRP, and leukocyte rich fibrin. By origin, it is classified into autologous PRP, allogeneic PRP, and homologous PRP. By application, it is divided into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and others. By geography, it is studied across North America, Europe, Asia Pacific, and LAMEA.

Key Benefits

Comprehensive analysis of factors that drive and restrict the growth of the global PRP market is provided.
The projections in the market are made by studying the current market trends and future market potential for the period (20172023) in terms of value.
Extensive analysis by technology and application helps understand the various trends and prevailing opportunities in the respective market
Key market players within the global PRP market are profiled in the market and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global PRP market.
Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographies.

Platelet Rich Plasma Market Key Segments:

By Product

Pure PRP
Leukocyte Rich PRP
Leukocyte Rich Fibrin

By Origin

Autologous PRP
Allogeneic PRP
Homologous PRP

By Application

Orthopedic Surgery
Cosmetic Surgery
General Surgery
Neurosurgery
Others

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

List of players profiled in the report

Arthrex, Inc.
Zimmer Biomet
Harvest Technologies Corporation
DePuy Synthes, Inc.
Stryker Corporation
AdiStem Ltd.
ISTO Biologics
Cesca Therapeutics, Inc.
Exactech Inc.
Nuo Therapeutics

Enquiry About Report

Please input above shown text into input box
or click refresh

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

License Type

Data Pack

Single User PDF

Five User Online/PDF

Enterprise Online/PDF

LICENSE INFO

Users/Sharing

Restricted to one authorized user

Limited to 5 authorized users

Unlimited within company / enterprise

Printing

One Print only

Up to Five Copies

Unlimited within company / enterprise

Delivery Formats

ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

Have questions ?
Speak with analyst

Did you miss anything?
To add more

* Taxes/Fees, If applicable, will be
added at the checkout. All prices in USD.

Need More Information

+1-503-894-6022

help@alliedmarketresearch.com

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Report Title: Platelet Rich Plasma Market by Product (Pure PRP, Leukocyte Rich PRP, and Leukocyte Rich Fibrin), by Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), and by Application (Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025

Select Chapters

Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8

Full Name: *:

Company Name: *:

Job Role: *:

Email: *:

Country: *:

Contact Number: *:

How can we help? *:

Security Code: *:

STAY WITH US

WE ACCEPT

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Chapter: 1 INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models
Chapter: 2 EXECUTIVE SUMMARY 2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW 3.1. MARKET DEFINITION AND SCOPE 3.2. KEY FINDINGS 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. MARKET SHARE ANALYSIS, 2016 3.4. PORTER’S FIVE FORCES ANALYSIS 3.5. MARKET DYNAMICS 3.5.1. Drivers 3.5.2. Restraints 356.3. Opportunities
Chapter: 4 PLATELET RICH PLASMA MARKET, BY PRODUCT 4.1. OVERVIEW 4.1.1. Market size and forecast 4.2. PURE PRP 4.2.1. Key market trends 4.2.2. Growth factors and opportunities 4.2.3. Market size and forecast 4.3. LEUKOCYTE RICH PRP 4.3.1. Key market trends 4.3.2. Growth factors and opportunities 4.3.3. Market size and forecast 4.4. LEUKOCYTE RICH FIBRIN 4.4.1. Key market trends 4.4.2. Growth factors and opportunities 4.4.3. Market size and forecast
Chapter: 5 PLATELET RICH PLASMA MARKET, BY ORIGIN 5.1. OVERVIEW 5.1.1. Market size and forecast 5.2. AUTOLOGOUS PRP 5.2.1. Market size and forecast 5.3. ALLOGENEIC PRP 5.3.1. Market size and forecast 5.4. HOMOLOGOUS PRP 5.3.1. Market size and forecast
Chapter: 6 PLATELET RICH PLASMA MARKET, BY APPLICATION 6.1. OVERVIEW 6.1.1. Market size and forecast 6.2. ORTHOPEDIC SURGERY 6.2.1. Market size and forecast 6.3. COSMETIC SURGERY 6.3.1. Market size and forecast 6.4. GENERAL SURGERY 6.4.1. Market size and forecast 6.5. NEUROSURGERY 6.5.1. Market size and forecast 6.6. OTHERS 6.6.1. Market size and forecast
Chapter: 7 PLATELET RICH PLASMA MARKET, BY GEOGRAPHY 7.1. OVERVIEW 7.2. NORTH AMERICA 7.2.1. Key market trends 7.2.2. Key growth factors and opportunities 7.2.3. Market size and forecast 7.2.3.1. U.S. market size and forecast 7.2.3.2. Canada market size and forecast 7.2.3.3. Mexico market size and forecast 7.2.4. North America Platelet Rich Plasma Market by Product 7.2.5. North America Platelet Rich Plasma Market by Origin 7.2.6. North America Platelet Rich Plasma Market by Application 7.3. EUROPE 7.3.1. Key market trends 7.3.2. Key growth factors and opportunities 7.3.3. Market size and forecast 7.3.3.1. Germany market size and forecast 7.3.3.2. France market size and forecast 7.3.3.3. UK market size and forecast 7.3.3.4. Italy market size and forecast 7.3.3.5. Spain market size and forecast 7.3.3.6. Rest of Europe market size and forecast 7.3.4. Europe Platelet Rich Plasma Market by Product 7.3.5. Europe Platelet Rich Plasma Market by Origin 7.3.6. Europe Platelet Rich Plasma Market by Application 7.4. ASIA-PACIFIC 7.4.1. Key market trends 7.4.2. Key growth factors and opportunities 7.4.3. Market size and forecast 7.4.3.1. Japan market size and forecast 7.4.3.2. China market size and forecast 7.4.3.3. India market size and forecast 7.4.3.4. Rest of Asia-Pacific market size and forecast 7.4.4. Asia-Pacific Platelet Rich Plasma Market by Product 7.4.5. Asia-Pacific Platelet Rich Plasma Market by Origin 7.4.6. Asia-Pacific Platelet Rich Plasma Market by Application 7.5. LAMEA 7.5.1. Key market trends 7.5.2. Key growth factors and opportunities 7.5.3. Market size and forecast 7.5.3.1. Latin America market size and forecast 7.5.3.2. Middle East market size and forecast 7.5.3.3. Africa market size and forecast 7.5.4. LAMEA Platelet Rich Plasma Market by Product 7.5.5. LAMEA Platelet Rich Plasma Market by Origin 7.5.6. LAMEA Platelet Rich Plasma Market by Application
Chapter: 8 COMPANY PROFILES 8.1. ARTHREX, INC. 8.1.1. Operating business segments 8.1.3. Business performance 8.1.3. Key strategic moves and developments 8.3. ZIMMER BIOMET 8.3.1. Operating business segments 8.3.3. Business performance 8.3.3. Key strategic moves and developments 8.3. HARVEST TECHNOLOGIES CORPORATION 8.3.1. Operating business segments 8.3.3. Business performance 8.3.3. Key strategic moves and developments 8.4. DEPUY SYNTHES, INC. 8.4.1. Operating business segments 8.4.3. Business performance 8.4.3. Key strategic moves and developments 8.5. STRYKER CORPORATION 8.5.1. Operating business segments 8.5.3. Business performance 8.5.3. Key strategic moves and developments 8.6. ADISTEM LTD. 8.6.1. Operating business segments 8.6.3. Business performance 8.6.3. Key strategic moves and developments 8.7. ISTO BIOLOGICS 8.7.1. Operating business segments 8.7.3. Business performance 8.7.3. Key strategic moves and developments 8.8. CESCA THERAPEUTICS, INC. 8.8.1. Operating business segments 8.8.3. Business performance 8.8.3. Key strategic moves and developments 8.9. EXACTECH INC. 8.9.1. Operating business segments 8.9.3. Business performance 8.9.3. Key strategic moves and developments 8.10. NUO THERAPEUTICS 8.10.1. Operating business segments 8.10.3. Business performance 8.10.3. Key strategic moves and developments

Purchase Options